|
|
|
|
| LEADER |
00000cam a2200000Mi 4500 |
| 001 |
EBOOKCENTRAL_ocn923264684 |
| 003 |
OCoLC |
| 005 |
20240329122006.0 |
| 006 |
m o d |
| 007 |
cr |n||||||||| |
| 008 |
151010s1900 dcu o 000 0 eng d |
| 040 |
|
|
|a EBLCP
|b eng
|e pn
|c EBLCP
|d OCLCQ
|d MERUC
|d OCLCQ
|d ZCU
|d ICG
|d OCLCO
|d OCLCF
|d OCLCQ
|d OCLCO
|d OCLCQ
|d DKC
|d AU@
|d OCLCQ
|d OCLCA
|d OCLCQ
|d OCLCO
|d OCLCQ
|d OCLCO
|d OCLCL
|
| 020 |
|
|
|a 9780309572033
|
| 020 |
|
|
|a 0309572037
|
| 029 |
1 |
|
|a DEBBG
|b BV044107260
|
| 035 |
|
|
|a (OCoLC)923264684
|
| 043 |
|
|
|a n-us---
|
| 050 |
|
4 |
|a HD9666.5.C
|
| 082 |
0 |
4 |
|a 338.4761510973
|
| 049 |
|
|
|a UAMI
|
| 100 |
1 |
|
|a Staff, National Academy of Engineering.
|
| 245 |
1 |
0 |
|a Competitive Status of the U.S. Pharmaceutical Industry :
|b the Influences of Technology in Determining International Industrial Competitive Advantage.
|
| 260 |
|
|
|a Washington :
|b National Academies Press,
|c 1900.
|
| 300 |
|
|
|a 1 online resource (102 pages)
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 588 |
0 |
|
|a Print version record.
|
| 505 |
0 |
|
|a ""The Competitive Status of the U.S. Pharmaceutical Industry""; ""Copyright""; ""Preface""; ""Contents""; ""Summary""; ""FINDINGS ON THE U.S. COMPETITIVE POSITION""; ""DETERMINANTS OF NATIONAL PHARMACEUTICAL COMPETITIVE ADVANTAGE""; ""OPTIONS FOR AMERICAN POLICY""; ""Trade Options""; ""Domestic Economic Options""; ""Regulatory Options""; ""1 Overview of U.S. Pharmaceutical Industry ""; ""EMERGENCE OF THE MODERN PHARMACEUTICAL INDUSTRY""; ""NATURE OF PHARMACEUTICAL COMPETITION""; ""BENEFITS AND RISKS OF TECHNICAL CHANGE""; ""OVERVIEW AND LIMITATIONS OF THIS STUDY""; ""NOTES""
|
| 505 |
8 |
|
|a ""2 Competitive Position of the U.S. Pharmaceutical Industry """"RESEARCH""; ""INNOVATION""; ""PRODUCTION""; ""SALES""; ""STRUCTURE""; ""TRADE""; ""SUMMARY""; ""NOTES""; ""3 Determinants of National Pharmaceutical Competitive Advantage ""; ""LABOR COSTS""; ""MARKET GROWTH""; ""NATIONAL SCIENTIFIC CAPACITY""; ""GENERAL RELATIVE DECLINE OF U.S. INDUSTRY""; ""INDUSTRIAL POLICY: REGULATION""; ""Greater Use of Expert Committees""; ""Greater Acceptance of Foreign Data""; ""Less Politicization of Drug Approval Process""; ""Greater Cooperation between Regulators and Industry""
|
| 505 |
8 |
|
|a ""INDUSTRIAL POLICY: TAXATION""""INDUSTRIAL POLICY: TRADE""; ""SUMMARY""; ""NOTES""; ""4 New Developments Affecting the Industry ""; ""SCIENTIFIC ADVANCES""; ""JAPANESE DEVELOPMENTS""; ""NOTES""; ""5 Options for American Industrial Policy ""; ""TRADE OPTIONS""; ""DOMESTIC ECONOMIC OPTIONS""; ""REGULATORY OPTIONS""; ""The IND Process""; ""Early Clinical Research""; ""Objectives of Investigational Drug Regulation""; ""Clinical Development Studies""; ""Preclearance of Clinical Research""; ""The NDA Process""; ""Application of the Standards for Drug Approval""
|
| 505 |
8 |
|
|a ""The NDA Submission and Its Review""""Utilization of Outside Expert Advice""; ""Application of the Standards for Drug Approval""; ""FDA Management""; ""Resources for the New Drug Review Process""; ""Improving Interactions with Industry""; ""Tracking the Review Process to Ensure Timeliness""; ""Conflict of Interest and Expert Advisers""; ""Improving Interactions with Industry""; ""NOTES""; ""6 Biographical Sketches ""; ""Index""
|
| 590 |
|
|
|a ProQuest Ebook Central
|b Ebook Central Academic Complete
|
| 650 |
|
0 |
|a Pharmaceutical industry
|x Technological innovations
|z United States.
|
| 650 |
|
0 |
|a Pharmaceutical industry
|z United States.
|
| 650 |
|
0 |
|a Competition
|z United States.
|
| 650 |
|
0 |
|a Drugs
|z United States
|x Marketing.
|
| 650 |
|
6 |
|a Industrie pharmaceutique
|z États-Unis.
|
| 650 |
|
7 |
|a Competition
|2 fast
|
| 650 |
|
7 |
|a Drugs
|x Marketing
|2 fast
|
| 650 |
|
7 |
|a Pharmaceutical industry
|2 fast
|
| 650 |
|
7 |
|a Pharmaceutical industry
|x Technological innovations
|2 fast
|
| 651 |
|
7 |
|a United States
|2 fast
|1 https://id.oclc.org/worldcat/entity/E39PBJtxgQXMWqmjMjjwXRHgrq
|
| 758 |
|
|
|i has work:
|a The competitive status of the U.S. pharmaceutical industry (Text)
|1 https://id.oclc.org/worldcat/entity/E39PCFXCwV8CBGvbdppjBYrYmq
|4 https://id.oclc.org/worldcat/ontology/hasWork
|
| 776 |
0 |
8 |
|i Print version:
|a Staff, National Academy of Engineering.
|t Competitive Status of the U.S. Pharmaceutical Industry : The Influences of Technology in Determining International Industrial Competitive Advantage.
|d Washington : National Academies Press, ©1900
|z 9780309033961
|
| 856 |
4 |
0 |
|u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=3376552
|z Texto completo
|
| 938 |
|
|
|a ProQuest Ebook Central
|b EBLB
|n EBL3376552
|
| 994 |
|
|
|a 92
|b IZTAP
|
